Health University School of Medicine-The changes in immune response of guinea pigs intrapleurally injected once with beryllium oxide (BeO) or beryllium copper alloy (Be-Cu) were examined. To evaluate the changes in immune response of guinea pigs, two indicators, beryllium lymphocyte transformation test (Be-LTT) and complement hemolytic activity (CH 50 ), were used. The BeO or Be-Cu injection groups was divided three groups, a high concentration injection group (36 µg Be dose), a low concentration injection group (3.6 µg Be dose) and the control group. The Be-LTT and CH 50 were determined in the blood of guinea pigs at 4, 8 and 16 weeks after Be administration. The Be-LTT value at the 4th week in the BeO groups (a high or low concentration injection group, respectively) showed a statistically significant increase (p<0.01) compared with that of the control. In the Be-LTT value for BeO at 8 and 16 weeks after Be injection and the Be-Cu groups, there were no statistical difference between the Be administration groups and the control. On the other hand, only the CH 50 of the high concentration group at the 8th week in the BeO injection group was significantly decreased (p<0.01) compared with that of the control. In the other Be injection group, no significant changes in the CH 50 was observed compared with the control group. On the basis of the results observed in the present study, there may be a slight difference in the effect on the immune response of guinea pigs caused by BeO or Be-Cu administration. The immunotoxicity of Be in guinea pigs may manifest itself more intensely in the cellular immune response than in the humoral immune response.
Beryllium (Be) and its compounds exert various effects on the living body and are highly dangerous, so a great deal of care has been required in handling them.
The toxicity of Be has been mostly elucidated, but some details of its immunotoxicity remain obscure. Furthermore, the immunotoxicity of Be has attracted attention from the immunological viewpoint. When Be is taken into the body, although a light metal of very low molecular weight, it exerts toxic effects on the immune system and causes a disturbance in the defence mechanism of the body 1, 2) . Chronic beryllium disease (CBD), in which pulmonary granuloma is caused by exposure to Be, is a typical lesion developed via cellular immune response according to an established theory 3) . But there is little literature on the relationship between the process of the formation of granuloma due to Be exposure and the actual changes in the immune response of the body.
We observed several times in the past the formation of pulmonary granuloma similar to human CBD in guinea pigs intrapleurally injected with beryllium oxide (BeO) [4] [5] [6] . In the present series of experiment, we examined the changes in the immune response of guinea pigs intrapleurally injected with BeO or beryllium-copper alloy (Be-Cu) causing CBD in man. To evaluate the changes in the immune response of guinea pigs, we used two indicators, beryllium lymphocyte transformation test (Be-LTT) and complement hemolytic activity (CH 50 ), then discussed the possible relationship between the Be lesion and the changes in immune response caused by Be exposure.
Materials and Methods

Experimental animals
Hartley strain male guinea pigs (250-300 g, Nihon Living Materials) were used.
Be suspensions for injection into guinea pigs
BeO of 99.9% purity and calcining temperature 800 to 1000°C, and Be-Cu with 1.8% Be content being were used. Both Be compounds were suspended in a 1% agar (Haechst Co., Ltd.) to make 36 µg/ml or 3.6 µg/ml as the Be dose and homogenized at 37°C before injection.
Be solution for determining mitogenesis of lymphocytes
A 2% solution of beryllium sulfate (Mitsuwa Chemical) in saline solution was prepared. The solution was diluted with saline to make 240, 120, 24, 12, 8, and 4 µM of beryllium, respectively.
Lymphocyte suspension
Using a lymphocyte isolation fluid for guinea pig (Ohtsuka Pharmaceutical Co.), the lymphocyte layer was separated from blood collected from the guinea pig heart. After washing twice with phosphate buffer (pH 7.4), the lymphocytes were suspended at a concentration of 1 × 10 6 cells/ml in RPMI 1640 cell culture medium (Flo Lab.) containing 10% guinea pig autoplasma and 5% fetal bovine serum (MOREGATE).
Mitogenesis assay
Lymphocytes (10 6 cells) were cultured in the presence of various final concentrations of Be(120, 60, 12, 6, 4, 2 µM) in cultures. They were cultured for 72 hr in a 37°C incubator (containing 5% CO 2 ). Subsequently, 9.25 kBq of 3 H-thymidine (Amersham, 3 H-TdR) was added and the suspensions were cultured again for 24 hr and then 3 H-TdR uptake in cells was determined with a liquid scintillation counter (Aloka). Tests were carried out on triplicate cultures per animal in five animals and the results were expressed as the mean counts per minute (cpm) of 3 H-TdR incorporation into cells. The intensity of mitogenesis of lymphocyte treated with Be was compared with that treated with 4 µ g/ml of phytohemaggulutinin (PHA).
Administration of Be
Oral, intraperitonial, subcutaneous or intradermal injection tests are generally used in Be administration experiments, because of the great danger in handling Be and its compounds. On the basis of our experience 4) , guinea pigs were intrapleurally injected with BeO or BeCu in this experiment.
Guinea pigs were grouped into the BeO injection group and Be-Cu injection group (45 animals in each). Each group was subdivided into three groups (15 in each), a high concentration injection group (36 µg Be dose), a low concentration group (3.6 µg Be dose), and the control group. The BeO or Be-Cu injection group was given 1 ml of the Be suspension for injection once from the right axillary of the guinea pigs using 26 G needle. On the other hand, the control group were given 1 ml of a 1% agar solution.
Preparation of blood lymphocytes and serum of guinea pigs injected with Be
Blood was collected from the heart of the guinea pigs (5 animals of each groups, respectively) at 4, 8, and 16 weeks after the Be administration. Blood lymphocytes for determining Be-LTT were isolated with a lymphocyte isolation fluid for guinea pigs, and serum for determining CH 50 was separated by centrifuging.
Be-LTT assay
The Be-LTT of each blood lymphocyte was determined according to the method of Williams et al. 7) with some modifications: 100 µl of the lymphocyte suspension (10 6 cells) and 100 µl of 8 µM Be solution were added to a microtiter plate. After incubating for 72 hr in 37°C CO 2 incubator, 9.25 kBq/well of 3 H-TdR was added, and the mixture was then incubated for 16 hr under the same conditions. With a cell harvester (Laboscience, LM101), lymphocytes were gathered on a glass fiber filter. After drying the filter, the amount of 3 H-TdR uptake by lymphocytes was measured in cpm with a scintillation counter.
Tests were carried out on triplicate cultures and the results expressed as stimulation index percentages (SI%): SI% = mean cpm of cultures with beryllium × 100 mean cpm of cultures without beryllium
The mean counts were derived from a triplicate series.
Serum CH 50 assay CH 50 was determined in sera isolated from the same blood as used in the Be-LTT determination. Determination was performed by a modified Mayer's method 8) . Sensitized sheep erythrocytes and each test serum were mixed in a gelatin veronal solution, and then reacted at 37°C for 60 min. Subsequently, the suspension was centrifuged, and the absorbance of the supernatant was determined in spectrophotometer at 541 nm. The complement hemolytic titer was computed from the value obtained.
Statistical methods
Statistical significance of the differences was evaluated by Student's t-test.
Results
In order to clarify whether Be has a mitogen-like reaction, the uptake of 3 H-TdR into Be-treated blood lymphocytes of guinea pigs was compared with that of untreated lymphocytes. The degree of the uptake was also compared with that of PHA treated lymphocytes. Furthermore, this experiment was carried out to determine the concentration of Be as antigen in the Be-LTT assay. When the final concentrations of Be in the cultures were 6 to 2 µM, the mitogenesis of Be-treated lymphocytes was most enhanced. From the results of this experiment, the concentration of Be as antigen in the Be-LTT assay was adjusted to 4 µM in the cultures. The results of treatment with 4 µM of Be are shown in Table 1 as the mean ± standard deviation (M ± S.D.) of 3 H-TdR uptake by lymphocytes. Thus, the mitogenesis of lymphocytes treated with Be in vitro was significantly enhanced in three of five tests compared with that of Be-untreated lymphocytes (p<0.01), but the degree of enhancement was very low compared with that of PHA-treated lymphocytes.
Next, to examine whether Be induces the cell mediated immune disorder, and to determine when the change in immune response appears after Be injection, the Be-LTT was carried out with the lymphocytes of guinea pigs intrapleurally injected once with BeO or Be-Cu. The results are shown as M ± S.D. of SI% in Table 2 . The Be-LTT in the high concentration BeO injection groups tended to increase compared with that of the Be-Cu injection groups. Moreover, the SI% of 36 µg BeO injection group tended to increase in any week compared with those of the other groups. Of all groups the Be-LTT at the 4th week in the BeO groups showed a statistically significant increase (p<0.01) compared with that of the control. On the other hand, the Be-LTT in the Be-Cu injection groups was not found to be significantly different from that of the control.
Next, to evaluate whether Be induces a humoral immune disorder, the changes in serum complement activity were examined in the same guinea pigs in which the Be-LTT was carried out. The results of the CH 50 are shown in Table 3 with M ± S.D. Only the CH 50 of the 36 µg group at the 8th week in the BeO injection groups The results are shown with M ± S.D. of SI%. The counts were derived from a series of triplicate cultures. *: Significant (p<0.01) compared to control.
was significantly decreased (p<0.01) compared with that of the control. In the other BeO groups and Be-Cu groups, no significant change in the CH 50 was observed compared with the control group.
Discussion
Chemical and structural factors of Be compounds, Be concentration in air and biological factors such as the sensitivity and hereditary disposition of the individuals contribute to the development of CBD.
Regarding the kinds of Be compounds, CBD caused by exposure to BeO has been exclusively reported. Nineteen of 21 cases of this disease reported in Japan developed due to exposure to BeO. The remaining two cases 9, 10) developed due to exposure to Be-Cu alloy.
Regarding the Be concentration in air, a continuous high level of Be exposure causes a high prevalence of CBD. CBD is a disease with formation of pulmonary granuloma as its chief sign. Generally the formation of granuloma is believed to be attributable to the long-term in vivo retention of a substance that cannot be decomposed by phagocytes such as macrophages or monocytes, resulting in continuous stimulation of macrophages by antigens or antigen-like substances. Continuous stimulation of alveolar macrophage by Be may trigger a series of immune responses, particularly a cellular immune-allergic mechanism, and it is believed to be closely associated with the formation of pulmonary granuloma 11) . We observed several times in the past the formation of pulmonary granuloma similar to human CBD in guinea pigs intrapleurally injected with BeO [4] [5] [6] . In view of the above-mentioned findings, we tried to elucidate the relationship between the actual state of cellular and humoral immune response and the process by which pulmonary granuloma is formed. The indicators of immune response used were Be-LTT and CH 50 . LTT is a test making use of the intracellular DNA synthesis when sensitized lymphocytes divide and proliferate with antigen stimulation. It is an excellent method to determine the activity of T cells and is an indicator of the state of the cellular immune response 12) . On the other hand, increased complement activity is caused by an antigen-antibody complex. The CH 50 is an indicator of the state of humoral immune response since it comprehensively reflects the complement activity from C 1 to C 9 . Based on the previous findings [4] [5] [6] , both immune responses were demonstrated at 4, 8 and 16 weeks after Be administration.
A lectin-like effect has been pointed out as one of the effects of Be 13, 14) . This is derived from enhancement of DNA synthesis of human or mouse lymphocytes. As a preliminary experiment, we studied the response of guinea pig blood lymphocytes to Be. An increase in intracellular DNA synthesis was observed, although it was extremely weak compared with the intensity stimulated with PHA. This shows that a lectine-like effect on guinea pig lymphocytes is caused by Be itself, and it suggests that the DNA synthesis of lymphocytes of guinea pigs injected with Be may be enhanced.
Next, the change in cellular immune response of guinea pigs injected with Be was seen at 4 weeks after BeO administration and a two-fold increase in the Be-LTT control value was noted. In the Be-LTT value at 8 and 16 weeks after BeO administration, there was no statistical difference between the Be administration group and the control group. On the basis of the data, the cellular immune response of guinea pigs for 16 weeks after BeO administration could be surmised as follows. T cells of guinea pigs injected with BeO might be sensitized relatively early by continuous stimulation of insoluble Be remaining near the lung field, and then the cellular immune response of guinea pigs might be enhanced. But with the lapse of time, the immune reactivity might be decreased, a phenomenon possibly related to the The results are shown with M ± S.D. for five experiments. *: Significant (p<0.01) compared to control.
disappearance of injected Be from the body. Considering that it took 8 and 16 weeks for pulmonary granuloma to be formed 4) , positive Be-LTT may be a phenomenon that occurs prior to the formation of granuloma. It is therefore surmised that the positive Be-LTT is used to predict the development of CBD. To check this, a logical verification with the data for Be-LTT should be done and pathological discussion would be needed. This point is being studied intensively in a series of experiments.
On the other hand, the Be-LTT value for guinea pigs injected with Be-Cu showed no remarkable change, meaning that the sensitization by Be has not been established. It may also be related to the absorption and excretion of Be-Cu injected into the body, because the sensitization by antigens is due to the antigen-presenting cells and continuous stimulation by antigens. In this case, injected Be-Cu might have been decomposed by alveolar macrophages, or the absorption-excretion of Be-Cu injected might occur more rapidly than with BeO. At least it is surmised that there might be less continuous stimulation of the cells effecting of immunity.
A change in CH 50 was seen only at the 8th week in the high BeO concentration group, a significant decrease in the CH 50 being noted. This decrease in CH 50 reflects the immunological phenomenon by which the activation of complement occurs after the enhancement of humoral immune response. But because some differences were noted between the control data in this experiment, it cannot determined only by the CH 50 value at the 8th week in the high BeO concentration group that Be induces the humoral immune disorder. We are now doing intensive research on this, and hope that it will be clarified in our next report. On the basis of the results of this experiment, some differences may be seen in the effect of Be on the immune response of guinea pigs BeO or Be-Cu administration. There may also be a difference in the effect of Be on the cellular or humoral immune response.
Conclusion
We administered BeO and Be-Cu alloy once intrapleurally to guinea pigs, and examined the immune response of guinea pigs 4, 8, and 16 weeks later with Be-LTT and CH 50 as the indicator. We discussed the relationship between the mechanism of development of CBD and the immune disorders induced by Be, and reached the following conclusions.
1. Be has a mitogen-like activity and an immunological sensitization.
2. BeO may has more immunotoxicity than Be-Cu.
The change in cellular immune response caused by
Be administration may occur relatively early after injecting guinea pigs with BeO. 4. The immunotoxicity of Be in guinea pigs may manifest itself more intensely in the cellular immune response than in the humoral immune response.
